Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Fuchs Dystrophy: later-stage trial registry
2 of 3 indexed Fuchs Dystrophy trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Fuchs Dystrophy: 3 US clinical trials tracked, 2 recruiting.
Fuchs Dystrophy is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Adam Fedyk, MD, FACS, running 1 of these trials.
Enrollment posture brief
Registry condition fuchs-dystrophy
OPEN 2 | RECR 67% | LATE 2 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Fuchs Dystrophy lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Fuchs Dystrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Fuchs Dystrophy is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Descemet Endothelial Thickness Comparison Trial II
Stanford University
NCT05275972
OCT in Fuchs' Dystrophy
Oregon Health and Science University
NCT04258787
The Evaluation of Balanced Salt Solution During Cataract Surgery
Adam Fedyk, MD, FACS
NCT05853978
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Fuchs Dystrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Fuchs Dystrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Fuchs Dystrophy page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Fuchs Dystrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Adam Fedyk, MD, FACS sponsors the most Fuchs Dystrophy trials on record, review their full trial history before evaluating a specific study. See Adam Fedyk, MD, FACS's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fuchs Dystrophy condition card totals 3 registered trials; most-linked intervention BSS; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.